Britt Newsome, MD
Nephrology · Thornton, CONPI 1306873476
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $613 of the $708 with a category attached, or 86.5%. It is spread thinly across 14 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $222, 2.7 times the $82 reported in 2019. That places this record below the midpoint for nephrology clinicians in CO, where the typical reported total is $627.
Across 23 payments — averaging $30.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$117
- Boehringer Ingelheim$110
- AstraZeneca$88
- Novartis$68
- Travere Therapeutics, Inc.$64
- Amgen$47
- plus $215 from 8 others
Across 2 payments — averaging $2272.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$5K
What the payments were for
- Food & beverage$61387%
- Education$9613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $117 |
| Boehringer Ingelheim | 1 | $110 |
| AstraZeneca | 4 | $88 |
| Novartis | 3 | $68 |
| Travere Therapeutics, Inc. | 3 | $64 |
| Amgen(2 entities) | 2 | $47 |
| Nxstage Medical, Inc. | 1 | $42 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
| Ardelyx, Inc. | 1 | $30 |
| Novo Nordisk | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Otsuka Pharmaceutical Co., Ltd. | 1 | $20 |
| Biomerieux Inc | 1 | $18 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$110
How this compares
$708 in reported general payments places this provider in the 50th percentile of 152 nephrology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 24 | $24,979 |
| FarxigaDapagliflozin Propanediol | 15 | $17,442 |
| EliquisApixaban | 11 | $9,804 |
| Tamsulosin Hcl | 13 | $305 |
| Amlodipine Besylate | 36 | $273 |
| Hydralazine Hcl | 15 | $160 |
| Lisinopril | 17 | $157 |
| Hydrochlorothiazide | 15 | $107 |
| Losartan Potassium | 15 | $97 |
| Allopurinol | 11 | $76 |
| Metoprolol Succinate | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLokelma, Farxiga | $88 | $42,42039 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 152 nephrology providers in Colorado.
Other nephrology in Thornton
- Michael ShomakerThornton$41K
- Geoffrey BlockLone Tree$726K
- Laura KooiengaDenver$82K
- Brad MarderDenver$77K
- Richard JohnsonAurora$62K
- Maria VelezDenver$47K
- Paul MillerGolden$42K
- Bruce KaplanAurora$42K
- Sixto GiustiAurora$23K
- Joseph AbdallahWestminster$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.